{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T14:01:52Z","timestamp":1781272912202,"version":"3.54.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T00:00:00Z","timestamp":1550880000000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Umbilical cord blood transplant (UCBT) is used for patients who do not have a matched donor, but engraftment often takes longer than with a standard allogeneic transplant, likely increasing the risk for infection. We characterized specific infections and outcomes in adults undergoing UCBT at our 2 centers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>All adults who underwent UCBT between January 1, 2006 and December 31, 2015 were included. Infectious episodes from 6 months before to 2 years after UCBT were reviewed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fifty-seven patients underwent UCBT; 47 had neutrophil engraftment. A total of 179 infectious episodes occurred in 55 patients, 73 (41%) within 30 days post-UCBT. Viruses caused 85 (47%) infections. Cytomegalovirus caused 32 infectious episodes and was most common from day 30 to 100. Human herpesvirus 6 occurred in 28 episodes, was most common within 30 days, and caused 1 death. Bacteria were responsible for 82 (46%) infections, most commonly bacteremias due to Staphylococcus spp, Enterococcus spp, and Enterobacteriaceae. Of 11 invasive fungal infections, 9 were aspergillosis, 4 of which were fatal. Overall mortality was 56% in the first year. Thirteen deaths were from infection; 11 occurred in the first 100 days and 7 in the first 30 days post-UCBT. Of 10 patients who never engrafted, 9 died, 6 from infection, within 100 days post-UCBT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Infectious complications were common after UCBT, especially in the first 30 days. Deaths from viral infections were fewer than expected. Delayed engraftment and nonengraftment continue to convey increased risk for fatal bacterial and fungal infections post-UCBT.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ofid\/ofz037","type":"journal-article","created":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T09:50:26Z","timestamp":1550915426000},"source":"Crossref","is-referenced-by-count":21,"title":["Infectious Complications After Umbilical Cord Blood Transplantation for Hematological Malignancy"],"prefix":"10.1093","volume":"6","author":[{"given":"Kathleen A","family":"Linder","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, University of Michigan Health System, Ann Arbor"},{"name":"Division of Infectious Diseases, Veterans Affairs Ann Arbor Healthcare System, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J","family":"McDonald","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Karmanos Cancer Center, Wayne State University School of Medicine, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A","family":"Kauffman","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Michigan Health System, Ann Arbor"},{"name":"Division of Infectious Diseases, Veterans Affairs Ann Arbor Healthcare System, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay G","family":"Revankar","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Karmanos Cancer Center, Wayne State University School of Medicine, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranatharthi H","family":"Chandrasekar","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Karmanos Cancer Center, Wayne State University School of Medicine, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3175-0512","authenticated-orcid":false,"given":"Marisa H","family":"Miceli","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Michigan Health System, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,2,22]]},"reference":[{"key":"2020081003480875400_CIT0001","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/sj.bmt.1705403","article-title":"Adult umbilical cord blood transplantation: a comprehensive review","volume":"38","author":"Schoemans","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"2020081003480875400_CIT0002","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1056\/NEJMoa041276","article-title":"Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia","volume":"351","author":"Laughlin","year":"2004","journal-title":"N Engl J Med"},{"key":"2020081003480875400_CIT0003","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.bbmt.2006.11.005","article-title":"A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients","volume":"13","author":"Hwang","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020081003480875400_CIT0004","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/BF02982652","article-title":"The kinetics of immune reconstitution after cord blood transplantation and selected CD34+ stem cell transplantation in children: comparison with bone marrow transplantation","volume":"77","author":"Inoue","year":"2003","journal-title":"Int J Hematol"},{"key":"2020081003480875400_CIT0005","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bbmt.2006.03.007","article-title":"Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation","volume":"12","author":"Parody","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020081003480875400_CIT0006","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1423-0410.2007.00900.x","article-title":"Infectious complications following unrelated cord blood transplantation","volume":"92","author":"van Burik","year":"2007","journal-title":"Vox Sang"},{"key":"2020081003480875400_CIT0007","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbmt.2014.01.001","article-title":"Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation","volume":"20","author":"Servais","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020081003480875400_CIT0008","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.bmt.1702089","article-title":"Immune reconstitution and outcome after unrelated cord blood transplantation: a single paediatric institution experience","volume":"25","author":"Giraud","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"2020081003480875400_CIT0009","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bbmt.2007.02.012","article-title":"Invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases","volume":"13","author":"Miyakoshi","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020081003480875400_CIT0010","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.bmt.1705140","article-title":"Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time","volume":"36","author":"Gratwohl","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"2020081003480875400_CIT0011","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/bmt.2010.177","article-title":"Reduction of infection-related mortality after allogeneic PBSCT from HLA-identical siblings: longitudinal analysis from 1994 to 2008 at a single institution","volume":"46","author":"Martino","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"2020081003480875400_CIT0012","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/bmt.2015.330","article-title":"Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation","volume":"51","author":"Tanaka","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"2020081003480875400_CIT0013","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.bbmt.2011.02.001","article-title":"Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin","volume":"17","author":"Sauter","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020081003480875400_CIT0014","doi-asserted-by":"crossref","first-page":"882","DOI":"10.6004\/jnccn.2016.0093","article-title":"Prevention and treatment of cancer-related infections, version 2.2016, NCCN clinical practice guidelines in oncology","volume":"14","author":"Baden","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"2020081003480875400_CIT0015","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020081003480875400_CIT0016","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) consensus group","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2020081003480875400_CIT0017","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2020081003480875400_CIT0018","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.bbmt.2009.07.021","article-title":"Infectious complications after unrelated umbilical cord blood transplantation in adult patients with hematologic malignancies","volume":"15","author":"Cahu","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020081003480875400_CIT0019","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/tid.12361","article-title":"Severe infections after single umbilical cord blood transplantation in adults with or without the co-infusion of CD34+ cells from a third-party donor: results of a multicenter study from the Grupo Espa\u00f1ol de Trasplante Hematopoy\u00e9tico (GETH)","volume":"17","author":"Martino","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"2020081003480875400_CIT0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJM199708073370602","article-title":"Outcome of cord-blood transplantation from related and unrelated donors. Eurocord transplant group and the European blood and marrow transplantation group","volume":"337","author":"Gluckman","year":"1997","journal-title":"N Engl J Med"},{"key":"2020081003480875400_CIT0021","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1182\/blood-2002-01-0294","article-title":"Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival","volume":"100","author":"Wagner","year":"2002","journal-title":"Blood"},{"key":"2020081003480875400_CIT0022","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbmt.2007.06.006","article-title":"Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources","volume":"13","author":"Walker","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020081003480875400_CIT0023","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bbmt.2011.05.015","article-title":"CMV infection after transplant from cord blood compared to other alternative donors: the importance of donor-negative CMV serostatus","volume":"18","author":"Mikulska","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020081003480875400_CIT0024","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbmt.2009.09.019","article-title":"Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation","volume":"16","author":"Beck","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020081003480875400_CIT0025","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.exphem.2014.07.264","article-title":"Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults","volume":"42","author":"Le Bourgeois","year":"2014","journal-title":"Exp Hematol"},{"key":"2020081003480875400_CIT0026","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.bbmt.2012.04.016","article-title":"Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis","volume":"18","author":"Hill","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020081003480875400_CIT0027","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/infdis\/jix042","article-title":"Association of the emergence of acyclovir-resistant herpes simplex virus type 1 with prognosis in hematopoietic stem cell transplantation patients","volume":"215","author":"Kakiuchi","year":"2017","journal-title":"J Infect Dis"},{"key":"2020081003480875400_CIT0028","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jiac.2017.02.001","article-title":"Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion","volume":"23","author":"Akahoshi","year":"2017","journal-title":"J Infect Chemother"},{"key":"2020081003480875400_CIT0029","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1182\/blood-2011-06-361618","article-title":"Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients","volume":"118","author":"Milano","year":"2011","journal-title":"Blood"},{"key":"2020081003480875400_CIT0030","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.3109\/10428194.2014.896007","article-title":"The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients","volume":"55","author":"Satlin","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"2020081003480875400_CIT0031","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.bbmt.2010.05.008","article-title":"The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients","volume":"16","author":"Kamboj","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020081003480875400_CIT0032","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/tid.12120","article-title":"Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients","volume":"15","author":"Kang","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"2020081003480875400_CIT0033","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/cid\/cis550","article-title":"Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation","volume":"55","author":"Vydra","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2020081003480875400_CIT0034","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/bmt.2014.150","article-title":"Risk factors for vancomycin-resistant Enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation","volume":"49","author":"Tavadze","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"2020081003480875400_CIT0035","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s12185-015-1745-9","article-title":"Clinical significance of nontuberculous mycobacteria from respiratory specimens in stem cell transplantation recipients","volume":"101","author":"Kang","year":"2015","journal-title":"Int J Hematol"},{"key":"2020081003480875400_CIT0036","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/sj.bmt.1700686","article-title":"Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review","volume":"19","author":"Roy","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"2020081003480875400_CIT0037","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1086\/383307","article-title":"Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients","volume":"38","author":"Cordonnier","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2020081003480875400_CIT0038","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the transplant-associated infection surveillance network (TRANSNET) database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2020081003480875400_CIT0039","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bbmt.2015.09.008","article-title":"Risk factors for acute and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation with umbilical cord blood and matched sibling donors","volume":"22","author":"Lazaryan","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020081003480875400_CIT0040","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood-2008-07-163238","article-title":"Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors","volume":"113","author":"MacMillan","year":"2009","journal-title":"Blood"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/6\/2\/ofz037\/33577032\/ofz037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/6\/2\/ofz037\/33577032\/ofz037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T02:15:10Z","timestamp":1721009710000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofz037\/5363895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofz037","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2019,2,1]]},"article-number":"ofz037"}}